本报道最初发表于Endpoints News。请点击这里查看原文
Isomorphic Labs said Tuesday it had closed a $2.1 billion Series B round, cementing its bellwether role in using AI for drug discovery.
Isomorphic Labs周二表示,公司已完成21亿美元的B轮融资(Series B),巩固了其在利用AI进行药物发现领域的风向标地位。
您已阅读2%(237字),剩余98%(9698字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。